CD4+ and CD8+ T lymphocyte levels prior to the diagnosis of CMV retinitis

R. T. Sy, H. K. Li, B. I. Dejean, M. I. Borucki, S. G. Hausrath, Richard B Pollard

Research output: Contribution to journalArticle

Abstract

Purpose: This study examined the decline in CD4 and CD8 levels in HIV seropositive patients who developed CMV retinitis. Methods: The records of HIV seropositive patients seen at the University of Texas Medical Branch in 1982-1995 were reviewed for T lymphocyte subsets prior to the onset of CMV retinitis. The ACCRP provides longitudinal, primary care for HIV-infected adults from a multi-county region of southeast Texas and for HIV-infected inmates of the Texas Department of Corrections. Results: Of 5,449 cases of HIV seropositive patients seen by the ACCRP, 1,551 patients had at least one CD4+ determination ≤ 50 CD4+/mm3 and 182 patients were diagnosed with CMV retinitis. The mean CD4+ was 32.54 ± 38/mm3 within ± 3 months of diagnosis of CMV retinitis, compared to 64.16 ± 75/mm3 within 6 to 12 months prior to the diagnosis of CMV retinitis (p<0.0005, unpaired student's t test). The mean CD8+ was 287± 217/mm3 within ± 3 months of diagnosis of CMV retinitis. The mean CD8+ was 479.97± 297/mm3 at 6 to 12 months prior to the diagnosis of CMV retinitis (p<0.0005). Conclusions: HIV seropositive patients who developed CMV retinitis had significantly lower mean CD4+ and CD8+ within ± 3 months of diagnosis of CMV retinitis compared to 6 to 12 months prior to the diagnosis. This data may have a predictive value for determining the optimal time to institute prophylactic treatment for CMV retinitis in HIV seropositive patients.

Original languageEnglish (US)
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996
Externally publishedYes

Fingerprint

Retinitis
T-Lymphocytes
HIV
T-Lymphocyte Subsets
Primary Health Care
Students

ASJC Scopus subject areas

  • Ophthalmology

Cite this

CD4+ and CD8+ T lymphocyte levels prior to the diagnosis of CMV retinitis. / Sy, R. T.; Li, H. K.; Dejean, B. I.; Borucki, M. I.; Hausrath, S. G.; Pollard, Richard B.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

Sy, R. T. ; Li, H. K. ; Dejean, B. I. ; Borucki, M. I. ; Hausrath, S. G. ; Pollard, Richard B. / CD4+ and CD8+ T lymphocyte levels prior to the diagnosis of CMV retinitis. In: Investigative Ophthalmology and Visual Science. 1996 ; Vol. 37, No. 3.
@article{facc83239b954f5088c7418a874a5f75,
title = "CD4+ and CD8+ T lymphocyte levels prior to the diagnosis of CMV retinitis",
abstract = "Purpose: This study examined the decline in CD4 and CD8 levels in HIV seropositive patients who developed CMV retinitis. Methods: The records of HIV seropositive patients seen at the University of Texas Medical Branch in 1982-1995 were reviewed for T lymphocyte subsets prior to the onset of CMV retinitis. The ACCRP provides longitudinal, primary care for HIV-infected adults from a multi-county region of southeast Texas and for HIV-infected inmates of the Texas Department of Corrections. Results: Of 5,449 cases of HIV seropositive patients seen by the ACCRP, 1,551 patients had at least one CD4+ determination ≤ 50 CD4+/mm3 and 182 patients were diagnosed with CMV retinitis. The mean CD4+ was 32.54 ± 38/mm3 within ± 3 months of diagnosis of CMV retinitis, compared to 64.16 ± 75/mm3 within 6 to 12 months prior to the diagnosis of CMV retinitis (p<0.0005, unpaired student's t test). The mean CD8+ was 287± 217/mm3 within ± 3 months of diagnosis of CMV retinitis. The mean CD8+ was 479.97± 297/mm3 at 6 to 12 months prior to the diagnosis of CMV retinitis (p<0.0005). Conclusions: HIV seropositive patients who developed CMV retinitis had significantly lower mean CD4+ and CD8+ within ± 3 months of diagnosis of CMV retinitis compared to 6 to 12 months prior to the diagnosis. This data may have a predictive value for determining the optimal time to institute prophylactic treatment for CMV retinitis in HIV seropositive patients.",
author = "Sy, {R. T.} and Li, {H. K.} and Dejean, {B. I.} and Borucki, {M. I.} and Hausrath, {S. G.} and Pollard, {Richard B}",
year = "1996",
month = "2",
day = "15",
language = "English (US)",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - CD4+ and CD8+ T lymphocyte levels prior to the diagnosis of CMV retinitis

AU - Sy, R. T.

AU - Li, H. K.

AU - Dejean, B. I.

AU - Borucki, M. I.

AU - Hausrath, S. G.

AU - Pollard, Richard B

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose: This study examined the decline in CD4 and CD8 levels in HIV seropositive patients who developed CMV retinitis. Methods: The records of HIV seropositive patients seen at the University of Texas Medical Branch in 1982-1995 were reviewed for T lymphocyte subsets prior to the onset of CMV retinitis. The ACCRP provides longitudinal, primary care for HIV-infected adults from a multi-county region of southeast Texas and for HIV-infected inmates of the Texas Department of Corrections. Results: Of 5,449 cases of HIV seropositive patients seen by the ACCRP, 1,551 patients had at least one CD4+ determination ≤ 50 CD4+/mm3 and 182 patients were diagnosed with CMV retinitis. The mean CD4+ was 32.54 ± 38/mm3 within ± 3 months of diagnosis of CMV retinitis, compared to 64.16 ± 75/mm3 within 6 to 12 months prior to the diagnosis of CMV retinitis (p<0.0005, unpaired student's t test). The mean CD8+ was 287± 217/mm3 within ± 3 months of diagnosis of CMV retinitis. The mean CD8+ was 479.97± 297/mm3 at 6 to 12 months prior to the diagnosis of CMV retinitis (p<0.0005). Conclusions: HIV seropositive patients who developed CMV retinitis had significantly lower mean CD4+ and CD8+ within ± 3 months of diagnosis of CMV retinitis compared to 6 to 12 months prior to the diagnosis. This data may have a predictive value for determining the optimal time to institute prophylactic treatment for CMV retinitis in HIV seropositive patients.

AB - Purpose: This study examined the decline in CD4 and CD8 levels in HIV seropositive patients who developed CMV retinitis. Methods: The records of HIV seropositive patients seen at the University of Texas Medical Branch in 1982-1995 were reviewed for T lymphocyte subsets prior to the onset of CMV retinitis. The ACCRP provides longitudinal, primary care for HIV-infected adults from a multi-county region of southeast Texas and for HIV-infected inmates of the Texas Department of Corrections. Results: Of 5,449 cases of HIV seropositive patients seen by the ACCRP, 1,551 patients had at least one CD4+ determination ≤ 50 CD4+/mm3 and 182 patients were diagnosed with CMV retinitis. The mean CD4+ was 32.54 ± 38/mm3 within ± 3 months of diagnosis of CMV retinitis, compared to 64.16 ± 75/mm3 within 6 to 12 months prior to the diagnosis of CMV retinitis (p<0.0005, unpaired student's t test). The mean CD8+ was 287± 217/mm3 within ± 3 months of diagnosis of CMV retinitis. The mean CD8+ was 479.97± 297/mm3 at 6 to 12 months prior to the diagnosis of CMV retinitis (p<0.0005). Conclusions: HIV seropositive patients who developed CMV retinitis had significantly lower mean CD4+ and CD8+ within ± 3 months of diagnosis of CMV retinitis compared to 6 to 12 months prior to the diagnosis. This data may have a predictive value for determining the optimal time to institute prophylactic treatment for CMV retinitis in HIV seropositive patients.

UR - http://www.scopus.com/inward/record.url?scp=33750189480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750189480&partnerID=8YFLogxK

M3 - Article

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -